As the nation's largest provider of newborn screening services, PerkinElmer Genetics is dedicated to improving the lives of children and their families by offering early detection of metabolic and other inherited disorders.
Metabolic and other inherited disorders are rare, but can be harmful, even deadly, when undetected.
Every state in the U.S. currently manages a program to screen newborns for inherited disorders. However, some states include only a handful of disorders in its program, leaving thousands of newborns unscreened for any number of potentially manageable disorders every year.
PerkinElmer Genetics offers the HRSA recommended screening for Severe Combined Immunodeficiency (SCID). This disorder has been included in our StepOne Screening Packet since April of 2010 and is now available as a stand-alone test in the SCID Only Screening Packet.
PerkinElmer Genetics offers StepOne®, a screening service that determines a baby's risk for more than 50 inherited disorders through an easily collected blood spot sample.